What Does the Published Research Say
doi: 10.1021/acs.jafc.1c05839
Through its transcriptional control of ferroptosis-regulatory components, including SLC7A11, GPX4 and FSP1, NRF2 creates a unified resistance program that simultaneously promotes tumor progression and confers therapeutic resistance (140)
Although high doses of T with finasteride do reduce AR mRNA, this effect appears to be due to the conversion of T to estradiol, since the aromatase inhibitor fadrazol blocks the effect.31 Estradiol in turn is a powerful in vitro down regulator, despite its lack of effect in the corpora cavernosa
When a peptide like Retatrutide is administered subcutaneously, it bypasses the entire digestive system
Knockout of SOD1 promotes conversion of selenocysteine to dehydroalanine in murine hepatic GPX1 protein